• About
  • Subscribe
  • Advertise
  • Contact
Wednesday, January 21, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

CooperVision releases new 1-day contact lens for presbyopes

by rhiannon bowman
July 19, 2021
in Business, Company updates & acquisitions, Contact Lenses, Local, News, Products
Reading Time: 3 mins read
A A
CooperVision MyDay presbyopia contact lens

Initial studies showed 86% of patients agreed the MyDay multifocal met their vision needs.

Share on FacebookShare on Twitter

New multifocal contact lenses by CooperVision featuring an innovative three-add approach that caters to all levels of presbyopia have launched on the Australian market today.

Expanding its silicone hydrogel 1-day family, the MyDay multifocal contact lenses are the first to feature CooperVision’s trademarked Binocular Progressive System, with simplified fitting, optimal visual acuity at all distances and comfortable wear, the company stated.

MyDay multifocal contact lenses are available in a power range of +8.00 diopters (D) to -10.00D in 0.25D steps, and -10.50D to -12.00D in 0.50D steps, and available in low (+0.75D to +1.25D), medium (+1.50D to +1.75D) and high (+2.00D to +2.50D) add power.

CooperVision ANZ brand manager Ms Jessie Taylor said single-vision contact lens wearers often lived active lifestyles, but as they became presbyopic, typically they were  unable to experience the same clear vision.

“As a result, they often turn to reading glasses [instead of] their contact lenses or drop out of the category entirely. With so many factors to consider, presbyopes need a contact lens that provides excellent vision, comfort, and health,” she said.

Taylor said CooperVision’s newest multifocal had the potential to help practices grow their contact lens patient base.

“MyDay multifocal contact lenses are ideal for younger presbyopes as well as patients with more advanced presbyopia looking for a way to stay in, return to, or begin contact lens wear,” she added.

Initial studies showed 86% of patients agreed that MyDay multifocal met their vision needs, and 90% of patient expectations were met or exceeded for vision stability during the day.

CooperVision’s new Binocular Progressive System, which it has debuted with the MyDay multifocal, features a three-add method that uses different lens designs to optimise vision for all levels of presbyopia. These allow the eyes to work in tandem for a simple initial fit and an easy progression as the near requirement increases.

The company said it now means optometrists can successfully fit 98% of patients with two pairs of MyDay multifocal lenses or fewer when following the fitting guide.

The MyDay multifocal fitting is incorporated into CooperVision’s OptiExpert app, which provides a suite of digital tools that aids clinical decision making, helps reduce chair time and increases patient success with contact lenses, the company said

“This includes a new capability of refining the first fit for vision optimisation,” the company said.

MyDay multifocal is designed with the same Aquaform Technology used in all MyDay and Biofinity lenses to provide patients with a high level of daily comfort and performance.

More information is available in the MyDay® multifocal fact sheet.

More reading

Expanded parameters for CooperVision toric

CooperVision releases toric multifocal for distinct patient cohort

 

Tags: Contact lensCooperVisionJessie TaylorMyDayMyDay multifocalpresbyopePresbyopia

Related Posts

The implant combines lab-grown human embryonic stem cell-derived RPE cells with an ultrathin synthetic parylene scaffold. Image: catalin/stock.adobe.com

Stem-cell retinal implant shows promise in dry AMD

by Staff Writer
January 21, 2026

Researchers in the United States are advancing a groundbreaking stem-cell retinal implant for people with advanced dry age-related macular degeneration...

There are plenty of pathways to help optometrists and dispensers into practice ownership. Image: Fxquadro/stock.adobe.com.

Webinar to help dispensers, optometrists into ownership

by Staff Writer
January 21, 2026

Optical Dispensers Australia (ODA), Eyecare Plus, ProVision, Vision Connection and Eyebenefit are working together to guide entrepreneurs and open the...

The glasses have a number of microphones built into the frames. Image: Nuance Audio.

Research evaluates Nuance Audio glasses in lab, real world

by Staff Writer
January 20, 2026

EssilorLuxottica has announced new clinical findings from two studies, including one in Australia, evaluating the performance of Nuance Audio glasses,...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited